Vulval cancer recurrent – European Clinical Trials Information Network https://clinicaltrials.eu Bridging Patients with Clinical Trials Fri, 12 Jun 2026 11:13:54 +0000 en-US hourly 1 https://wordpress.org/?v=7.0 https://clinicaltrials.eu/wp-content/uploads/2024/12/cropped-EU_icon-32x32.png Vulval cancer recurrent – European Clinical Trials Information Network https://clinicaltrials.eu 32 32 Study on Electrochemotherapy with Carboplatin and Bleomycin for Women with Relapsed Vulvar Cancer After Multiple Treatments https://clinicaltrials.eu/trial/study-on-electrochemotherapy-with-carboplatin-and-bleomycin-for-women-with-relapsed-vulvar-cancer-after-multiple-treatments/ Wed, 29 Apr 2026 15:02:28 +0000 https://clinicaltrials.eu/trial/study-on-electrochemotherapy-with-carboplatin-and-bleomycin-for-women-with-relapsed-vulvar-cancer-after-multiple-treatments/ This clinical trial is focused on studying a type of cancer called vulvar cancer, which affects the external part of the female genital organs. The study is specifically looking at cases where the cancer has returned after multiple treatments. The trial is testing a treatment method called electrochemotherapy, which combines electrical pulses with chemotherapy drugs to help the drugs enter cancer cells more effectively. The medications being tested in this study are Bleomycin and Carboplatin. Bleomycin is a drug that is injected into the bloodstream to help stop cancer cells from growing. Carboplatin is another drug used in chemotherapy that is also given through an injection.

The purpose of this study is to find out if using both Carboplatin and Bleomycin together is more effective than using Bleomycin alone in preventing the cancer from getting worse. Participants in the study will receive either the combination of Carboplatin and Bleomycin or just Bleomycin. The study will take place over a period of time, with regular check-ups to monitor the progress of the treatment. The treatment will be given through an intravenous injection, which means it will be administered directly into a vein.

Throughout the study, participants will be closely monitored to see how well the treatment is working and to check for any side effects. The main goal is to see if the combination treatment can help keep the cancer from progressing for a longer period compared to using Bleomycin alone. This study aims to provide valuable information that could improve treatment options for women with relapsed vulvar cancer.

]]>